Citius Pharma(CTXR) - 2024 Q4 - Annual Report

Grade II Hemorrhoids prolapse and reduce spontaneously with or without bleeding. Development Activities to Date As part of this Phase 2 trial, information was obtained relating to the use of the GSDS as an assessment tool for measuring the effectiveness of the test articles. Individual signs and symptoms were also assessed but can vary from patient to patient. Therefore, the goal of the GSDS was to provide an assessment tool that could be used for all patients regardless of which signs and symptoms they are ...